Auto-injectors Market Likely to Witness Notable Growth by 2027 | Becton, Sanofi, Pfizer

Autoinjector devices are used for administering insulin and other medications. These devices are often used in the field of diabetes care where precision is critical. Such devices generally consist of a pump that contains a reservoir that holds the medication that is connected to a syringe at its end. The needle that comes into contact with the pump is usually small enough not to produce any visible signs of blood or infection in the area in which it is inserted. These devices are very reliable and can be used to administer a wide range of medications.

Request Sample Report + Related Graphs & Charts @:
https://www.coherentmarketinsights.com/insight/request-sample/1035

Drivers

Increasing initiatives by companies to make auto-injectors available to patients suffering from anaphylaxis is expected to propel growth of the global auto-injectors market. For instance, Mylan N.V. provides discount cards to epinephrine buyers, and offers discounts up to US$ 300 on branded version of EpiPen and up to US$ 25 on the approved generic version of EpiPen.

Global Auto-Injectors Market: Opportunities
Decrease in the prices of auto-injectors is expected to offer lucrative growth opportunities for players in the global auto-injectors market. For instance, in December 2018, Kaléo announced to offer an authorized generic of its EVZIO (naloxone HCl injection) take home naloxone product at a list price of US$ 178 per carton of two auto-injectors.

Recent Developments

Major players operating in the global auto-injectors market are focused on R&D to expand their product portfolio. For instance, in September 2019, Emergent BioSolutions Inc. received around US$ 20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) for the treatment of nerve agent-induced seizures.
Global Auto-Injectors Market: Restraints
High cost of auto-injectors and stringent regulatory scenario for approval of auto-injectors is expected to limit growth of the global auto-injectors market. For instance, the cost of EpiPen (2-pack) increased from US$ 100 in 2007 to US$ 608.

Covid-19 Impact Analysis:

Globally, as of 4:32pm CEST, 15 October 2021, there have been 239,437,517 confirmed cases of COVID-19, including 4,879,235 deaths, reported to WHO. As of 14 October 2021, a total of 6,495,672,032 vaccine doses have been administered. The emergence of Covid-19 has led to increasing preference for self-administration of injections and development and launch of new products. For instance, In February 2021, Phillips-Medisize, a Molex company, collaborated with Subcuject, a developer of device platforms, for research and development of wearable bolus injector.

Request for customization in Report @ https://www.coherentmarketinsights.com/insight/request-customization/1035

The global auto-injectors market is estimated to account for US$ 2,338.2 Mn in 2018 in terms of value and is expected to reach US$ 7,894.6 Mn by the end of 2027.

The prefilled auto-injectors sub segment in product type segment in the global auto-injectors market was valued at US$ 1,904.1 Mn in 2018 and is expected to reach US$ 7,266.6 by 2027 at a CAGR of 15.1% during the forecast period.

The anaphylaxis sub segment in indication segment held dominant position in the global auto-injectors market in 2018, accounting for 89.2% share in terms of value, followed by multiple sclerosis and rheumatoid arthritis, respectively.

The online pharmacies sub segment in distribution channel segment held dominant position in the global auto-injectors market in 2018, accounting for 35.7% share in terms of value.

Market Trends:

Major players operating in the global auto-injectors market are focused on product launch to expand their product portfolio. For instance, in August 2019, ALK launched new epinephrine auto-injector that is designed to be small, easy-to-use, heat-stable, and with a long shelf life, in the U.S.

Major players operating in the global auto-injectors market include, Antares Pharma, Inc., Amgen Inc., Bayer AG, Becton, Dickinson and Company, Eli Lilly and Company, Janssen Global Services, LLC, Mylan N.V., Novartis International AG, Pfizer, Inc., and Sanofi,

Get Discount On The Purchase Of This Report @: https://www.coherentmarketinsights.com/promo/buynow/1035

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.